Sanofi, GSK to provide 200 million Covid vaccine doses to WHO global immunization program

Sanofi and GSK's vaccine is further behind in clinical development than some of the front-runners like Pfizer, Moderna and AstraZeneca, which are all in late-stage trials.

from Health and Science https://ift.tt/3jzasLO
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH